​Meet the scientists behind Transfidelity

​15th April at 6:00 pm CET

​Speakers List

​- Brian Magierski (Founding Steward at Cerebrum DAO)

​- Dr. Dimitri Scherbakov (Lead Researcher at Transfidelity)

​- Dr. Rashid Akbergenov (Lead Researcher at Transfidelity)

​- Logan Bishop-Currey (Biotech Operations Manager at Molecule)

​Neurodegenerative diseases such as Alzheimer's Disease are devastating conditions that impact millions globally. These diseases are driven by the misfolding and aggregation of proteins, which lead to brain cell death and cognitive decline. To make matters worse, as we age our cells become more error-prone, resulting in more errors during protein printing, causing proteins to clump together and form aggregates.

​Project Transfidelity aims to solve this by improving the accuracy of protein printing, preventing toxic aggregates from forming. Led by Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov, with over 50 years of combined experience in the lab, we have identified two molecules that may improve the efficiency of protein production, potentially preventing protein aggregates, hypothesized to cause dementia.